Your browser doesn't support javascript.
loading
VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke.
Cao, Xiang; Li, Feifei; Xin, Hongliang.
Affiliation
  • Cao X; Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China; Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
  • Li F; Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China. Electronic address: lifeifei@njmu.edu.cn.
  • Xin H; Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China. Electronic address: xhl@njmu.edu.cn.
Mol Ther ; 32(5): 1192-1194, 2024 May 01.
Article in En | MEDLINE | ID: mdl-38631352
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ischemic Stroke Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2024 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ischemic Stroke Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2024 Document type: Article Affiliation country: China